Scholars Central

Conference abstractPublished 22 Jun 2020

Money matters: A review of cost effective biologic prescribing at a Large Acute University Hospital

Authors: Sapna Gohil

University Hospitals of Coventry and Warwickshire, United Kingdom

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The practice of non-medical switching between originator biologic medicines and biosimilars resonates with recommendations from Lord Carter’s 2016 UK report regarding adoption of cost saving opportunities. In 2018/19, UHCW actioned one of the largest non-medical biosimilar switches for adalimumab. This quantitative review explores the success of the adalimumab biosimilar switch and key themes associated with switch backs/refusals across the Dermatology (D), Rheumatology (R) and Gastroenterology (G) specialities at UHCW. 403 patients eligible for switch (R;189, G;176, D; 38) were considered between April-December 2019. Patients were informed in advance via a patient information leaflet/hospital clinic visits. Switch refusals, withheld treatments and cancellations were documented. Clinicians would provide alternative management plans for patients who reported significant concerns post switch. 264/403 patients successfully switched (R;122, G;109, D;33). 33/403 patients switched back to the originator (R;22, G;10; D;1). Of the 33 switch back patients; 12(36%)=reported lack of efficacy; 8(24%)=injection site pain and 13(39%)=various other factors such as blepharitis, unstable disease and pregnancy. 38/403 patients refused the switch and remained on the originator biologic (R;11, G;27, D;0). 29/403 patients switched to an alternative biologic (R;17, G;9, D;3). 32/403 patients stopped treatment (R;13, G;19, D;0). Treatment was withheld for 7/403 patients (R;4, G;2, D;1). In summary, 66% of all eligible patients switched; thus an annual cost saving of £73,020. Dermatology achieved the most success in switching 87% of their patients. Injection site pain and subjective lack of efficacy were the predominant causative themes for switch backs.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Sapna Gohil”